Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Neurofibromatosis 1 · Plexiform Neurofibroma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Childrens of Alabama, Birmingham, Alabama, United States

    Contact: Study coordinator (Manjul Virmani, BS) · manjulvirmani@uabmc.edu · 205-638-6259
    Contact: Study coordinator (Britney McKenzie) · britneymckenzie@uabmc.edu · 205-638-6259
    Contact: Principal Investigator (Girish Dhall, MD)
    Laura Katie Metrock, MD (Sub-investigator)
  • Children's Hospital of Los Angeles, Los Angeles, California, United States

    Contact: Study coordinator (Tena Rosser, MD) · trosser@chla.usc.org · 323-361-2471
    Contact: Study coordinator (Martha Arellano-Garcia, MS) · margarcia@chla.usc.edu · 323-361-5812
    Contact: Principal Investigator (Tena Rosser, MD)
    Nathan Robison, MD (Sub-investigator)
  • Stanford University, Palo Alto, California, United States

    Contact: Study coordinator (Cynthia Campen, MD) · ccampen@stanford.edu · 650-497-8953
    Contact: Principal Investigator (Cynthia Campen, MD)
  • Children's National Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Benjamin Siegel, MD) · NF@childrensnational.org · 202-476-5181
    Contact: Principal Investigator (Benjamin Siegel, MD)
  • Lurie Children's Hospital of Chicago, Chicago, Illinois, United States

    Contact: Study coordinator (Kelly Bruno) · kbruno@luriechildrens.org · (312)227-4810
    Contact: Principal Investigator (Miriam Bornhorst, MD)
  • University of Chicago, Chicago, Illinois, United States

    Contact: Study coordinator (Cynthia MacKenzie) · cmackenzie@peds.bsd.uchicago.edu · 773-702-6487
    Contact: Principal Investigator (James Tonsgard, MD)
  • Riley Hospital for Children/Indiana University, Indianapolis, Indiana, United States

    Contact: Study coordinator (Steven Rhodes, MD, PhD) · RileyNFnurse@iuhealth.org · (317) 948-6641
    Contact: Principal Investigator (Steven Rhodes, MD, PhD)
  • Johns Hopkins University, Baltimore, Maryland, United States

    Contact: Study coordinator (Joshua Roberts, PhD) · jrobe112@jhmi.edu · (410) 955-6827
    Contact: Principal Investigator (Jaishri Blakeley, MD)
  • National Cancer Institute/ National Institutes of Health, Bethesda, Maryland, United States

    Contact: Study coordinator (Hemaxi Patel) · hemaxi.patel@nih.gov · 240-243-8838
    Contact: Principal Investigator (Brigitte Widemann, MD)
  • Boston Children's Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Olivia Clancy) · Olivia.Clancy@childrens.harvard.edu · 617-919-0291
    Contact: Principal Investigator (Nicole Ullrich, MD, PhD)
  • Mayo Clinic, Rochester, Minnesota, United States

    Contact: Study coordinator (Meg Connors) · rstclinicalgenomics@mayo.edu · 507-266-2275
    Contact: Principal Investigator (Radhika Dhamija, MBBS)
  • Washington University - St. Louis, St Louis, Missouri, United States

    Contact: Study coordinator (Amy Armstrong, MD) · armstrongae@wustl.edu · 314-454-6018
    Contact: Principal Investigator (Amy Armstrong, MD)
  • Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States

    Contact: Study coordinator (Lori Backus) · Peter.deBlank@cchmc.org; lori.backus@cchmc.org · 513-517-2068
    Andrea Gross, MD (Sub-investigator)
  • Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Ratnakar Patti) · pattir@email.chop.edu · 267-426-5503
    Contact: Principal Investigator (Michael Fisher, MD)
  • University of Texas, Southwestern, Dallas, Texas, United States

    Contact: Study coordinator (Laura Klesse, MD, PhD) · NFCMCUT@groups.utsouthwestern.edu · (214) 456-2382
    Contact: Principal Investigator (Laura Klesse, MD, PhD)